New report upgrades HeartBeam to buy, raises 12-month price target to $4, citing regulatory progress and company’s transition toward commercialization. Joseph Gunnar characterized the FDA clearance of ...
Datavault AI (NASDAQ: DVLT) highlighted a significant increase in institutional ownership between the fourth quarter of 2025 and February 2026, with Vanguard expanding its holdings to approximately 11 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results